Gjensidige Forsikring ASA (OTCMKTS:GJNSY – Get Rating) was upgraded by investment analysts at UBS Group from a “sell” rating to a “neutral” rating in a research note issued on Thursday, The Fly reports.
A number of other research firms have also weighed in on GJNSY. HSBC upgraded shares of Gjensidige Forsikring ASA from a “hold” rating to a “buy” rating in a research report on Monday, May 23rd. Credit Suisse Group boosted their target price on shares of Gjensidige Forsikring ASA from 237.00 to 242.00 and gave the stock an “outperform” rating in a report on Thursday, April 28th. Barclays boosted their target price on shares of Gjensidige Forsikring ASA from 255.00 to 260.00 and gave the stock an “overweight” rating in a report on Tuesday, June 7th. Finally, Citigroup downgraded shares of Gjensidige Forsikring ASA from a “neutral” rating to a “sell” rating in a report on Wednesday, July 13th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $251.00.
Gjensidige Forsikring ASA Trading Up 3.2 %
GJNSY opened at $21.20 on Thursday. Gjensidige Forsikring ASA has a 1-year low of $18.49 and a 1-year high of $26.74. The company has a 50 day simple moving average of $20.47 and a two-hundred day simple moving average of $22.75.
About Gjensidige Forsikring ASA
Gjensidige Forsikring ASA provides general insurance and pension products in Norway, Sweden, Denmark, Latvia, Lithuania, and Estonia. The company operates through six segments: General Insurance Private, General Insurance Commercial, General Insurance Denmark, General Insurance Sweden, General Insurance Baltics, and Pension.
- Get a free copy of the StockNews.com research report on Gjensidige Forsikring ASA (GJNSY)
- Procter’s Earnings Start To Show Weakness In Q4
- MarketBeat: Week in Review 7/25 – 7/29
- The One Question You Have to Ask Before Investing in INTC Stock
- Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
- Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
Receive News & Ratings for Gjensidige Forsikring ASA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gjensidige Forsikring ASA and related companies with MarketBeat.com's FREE daily email newsletter.